Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Marta Iraola Iribarren

Moderna starts human trials for Bundibugyo Ebola vaccine as Congo's outbreak continues

The first participants in Moderna’s clinical trial have been vaccinated against Bundibugyo Ebola virus as the company begins Phase 1 trials in Canada.

The vaccine is being developed using Moderna's mRNA platform, the same underlying technology used in its COVID-19 vaccine, the company said in a press release.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.